Jack W. Singer, EVP, Chief Scientific Officer at CTI BIOPHARMA CORP (CTIC), sold 18,000 shares at $1.17 ($21K) on 2016-01-29, disclosed to the SEC on 2016-01-29.
Open-market sale of $21k CTIC by EVP, Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.17 | 5,100 | $6K | 28.0% |
| 2 | $1.18 | 700 | $823 | 3.9% |
| 3 | $1.18 | 2,500 | $3K | 13.9% |
| 4 | $1.18 | 700 | $826 | 3.9% |
| 5 | $1.19 | 2,000 | $2K | 11.1% |
| 6 | $1.19 | 2,000 |
| $2K |
| 11.2% |
| 7 | $1.19 | 1,800 | $2K | 10.1% |
| 8 | $1.20 | 300 | $359 | 1.7% |
| 9 | $1.20 | 2,600 | $3K | 14.7% |
| 10 | $1.20 | 300 | $360 | 1.7% |
| Total | $1.18 avg | 18,000 | $21K | 100% |
| Filing → |
| CTIC | SELL | 2015-11-30 | $18K | — | Filing → |
| CTIC | SELL | 2015-10-23 | $24K | — | Filing → |
| CTIC | SELL | 2015-10-01 | $142K | — | Filing → |